{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:21:28Z","timestamp":1787556088782,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cmi.2026.06.016","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:17:59Z","timestamp":1782231479000},"page":"1510-1516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of generic market entry on the consumption of last-resort antibiotics in six European countries"],"prefix":"10.1016","volume":"32","author":[{"given":"Caroline","family":"Schweizer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Kesselmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.06.016_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.06.016_bib2","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1473-3099(18)30296-2","article-title":"Quantifying drivers of antibiotic resistance in humans: A systematic review","volume":"18","author":"Chatterjee","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.06.016_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: A cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.06.016_bib4","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2026.06.016_bib5","article-title":"Loss of exclusivity of ceftazidime\/avibactam in low- and middle-income countries: A test for antibiotic stewardship practice","volume":"15","author":"Veeraraghavan","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.cmi.2026.06.016_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jhealeco.2009.11.007","article-title":"Monopoly pricing of an antibiotic subject to bacterial resistance","volume":"29","author":"Herrmann","year":"2010","journal-title":"J Health Econ"},{"key":"10.1016\/j.cmi.2026.06.016_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40258-018-0406-6","article-title":"The impact of patent expiry on drug prices: A systematic literature review","volume":"16","author":"Vondeling","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.cmi.2026.06.016_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1744133112000084","article-title":"The impact of pricing and patent expiration on demand for pharmaceuticals: An examination of the use of broad-spectrum antimicrobials","volume":"8","author":"Kaier","year":"2013","journal-title":"Health Econ Policy Law"},{"key":"10.1016\/j.cmi.2026.06.016_bib9","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/jac\/dkq093","article-title":"Effect of generics on price and consumption of ciprofloxacin in primary healthcare: The relationship to increasing resistance","volume":"65","author":"Jensen","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.06.016_bib10","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1038\/s41467-021-23049-4","article-title":"The effect of generic market entry on antibiotic prescriptions in the United States","volume":"12","author":"K\u00e5llberg","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2026.06.016_bib11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/antibiotics10101149","article-title":"Impact of generic entry on hospital antimicrobial use: A retrospective quasi-experimental interrupted time series analysis","volume":"10","author":"Espona","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2026.06.016_bib12","series-title":"The selection and use of essential medicines 2023: Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines, April 24\u201328","article-title":"WHO AWaRe (access, watch, reserve) classification of antibiotics for evaluation and monitoring of use, 2023","year":"2023"},{"key":"10.1016\/j.cmi.2026.06.016_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293423","article-title":"Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus bloodstream infections: A systematic literature review and meta-analysis","volume":"19","author":"Adamu","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2026.06.016_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cir895","article-title":"Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: A randomized, controlled study","volume":"54","author":"Wunderink","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26003289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26003289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:51:43Z","timestamp":1787554303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26003289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1198743X26003289"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.06.016","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of generic market entry on the consumption of last-resort antibiotics in six European countries","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}